SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-130647
Filing Date
2023-05-01
Accepted
2023-05-01 17:12:31
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d463574d10ka.htm   iXBRL 10-K/A 263013
2 EX-31.1 d463574dex311.htm EX-31.1 4912
3 EX-31.2 d463574dex312.htm EX-31.2 4924
  Complete submission text file 0001193125-23-130647.txt   501335

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coya-20221231.xsd EX-101.SCH 4995
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE coya-20221231_cal.xml EX-101.CAL 687
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE coya-20221231_def.xml EX-101.DEF 1692
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20221231_lab.xml EX-101.LAB 21412
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20221231_pre.xml EX-101.PRE 17205
10 EXTRACTED XBRL INSTANCE DOCUMENT d463574d10ka_htm.xml XML 8155
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41583 | Film No.: 23874982
SIC: 2834 Pharmaceutical Preparations